Antitumor activities of interleukin-27 on melanoma.
The worldwide incidence of malignant melanoma has been steadily increasing, and it has become a major public health problem in many countries. Melanoma has been considered as a prototypical "immunogenic" tumor on the basis of clinical observations showing that primary lesions can spontaneously regress and that immunosuppressed individuals have an increased incidence of melanoma. Thus, various immunological therapies have been intensively conducted for the treatment of melanoma. Interleukin(IL)-27 is a IL-12-related heterodimeric cytokine composed of p28 and EBV-induced gene 3 subunits that are structurally related to the p35 and p40 subunits of IL-12, respectively. Recent studies reveal that IL-27 exhibits not only potent antitumor immune activities via cytotoxic T lymphocytes or natural killer cells but also an antiangiogenic effect. We recently clarified that IL-27 possesses an antiproliferative activity on melanoma cells. This review summarizes anti-tumor responses induced by IL-27 and novel anti-melanoma activities of IL-27.
Nagai
Hiroshi
H
Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan. hnagai@med.kobe-u.ac.jp
Oniki
Shuntaro
S
Fujiwara
Susumu
S
Xu
Mingli
M
Mizoguchi
Izuru
I
Yoshimoto
Takayuki
T
Nishigori
Chikako
C
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D020381:Interleukin-17 / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D007378:Interleukins / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D018123:Receptors, Interleukin / Q000235:genetics / Q000502:physiology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology
D000970:Antineoplastic Agents; C112441:IL27RA protein, human; D020381:Interleukin-17; D007378:Interleukins; C464565:MYDGF protein, human; D018123:Receptors, Interleukin